Y Combinator alumnus garners spotlight for clinical data analytics

Rick Morrison has boosted his profile in the biopharma scene since his startup Comprehend Systems graduated from the celebrated Y Combinator program. The company garnered a $1.2 million round of seed money from a lineup of Silicon Valley heavyweights, and much of the attention stems from the key need Comprehend addresses: Analyzing and visualizing clinical trials data from disparate sources all in one place.

Morrison, 31, picked up 2012 PharmaVoice 100 honors recently and has become a sought-after speaker on the use of cloud computing and data integration, among other hot topics in biopharma. Comprehend Systems, which FierceBiotechIT highlighted in 2011 as one to watch, sprung to life in 2010 after Morrison saw that existing analytics tools for clinical trial data required heavy implementation efforts and customization.

The company, which unveiled its flagship Comprehend Clinical product at DIA in 2011, announced in June the release of a cloud-based version of the software to offer users a hosted version of the clinical data analytics and visualization software. This spring Morrison told me that his company's strategy is to target CROs and large clinical trial software providers as initial customers for his company's product. And the firm has been able to show with early users that the software works as advertised.

"Now it's completely validated and it's … going into production" with customers, Morrison told FierceBiotechIT earlier this year. "We have several pilots nearing completion. There's a lot of excitement."

- here's Morrison's recent interview with Outsourcing-Pharma
- see the PharmaVoice profile

Related Articles
Bay Area startup delivers clinical trials analytics from the cloud
Check the pulse of biotech IT in Boston
Y Combinator alum Comprehend lands $1.2M seed round for clinical data analytics

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.